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the reinforcement of clinical remission and increased the life
expectancy of patients with brain tumors after surgery.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.068
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Objective: To study the impact of oxidative stress acute
hypoxia and reperfusion on HeLa cervical cancer cell attachment,
survival and invasion capacities.
Summary background data: Many hypotheses have been pro-
posed to explain the mechanism of port-site metastases (PSM).
We presumed that CO2 exposure results in hypoxia and reperfu-
sion with subsequent oxidative stress of cancer cells being a trig-
gering mechanism of PSM.
Methods: Two CO2-pneumoperitoneum conditions were cre-
ated: the hypoxic standard model (HSM) and oxidative stress
model (OSM) upon CO2 insufflation and reperfusion by means
of in vitro cell culture tools and non-exposed cells were served
as intact control. HeLa cervical cancer cells were exposed under
these CO2 insufflation conditions. Subsequently, HeLa cell
attachment, viability and proliferation capacities were evaluated
in duplicate samples as series I and II by the MTT and SRB
assays and invasion by the Matrigel invasion assay and repeated
in triplicate experiments. The impact of different CO2-
pneumoperitoneum conditions on cancer cell attachment was
evaluated immediately after exposure, whereas invasion capacity
after 48 h of incubation and survival and proliferation every 24 h
for 72 h.
Results: Both CO2 insufflation models significantly affected
HeLa cell attachment activity (p < 0.001) in comparison with that
of non-exposed cells. CO2 insufflation by HSM resulted in signif-
icantly pronounced weakening of HeLa cell attachment as com-
pared to exposure of these cells to insufflation by OSM
(p < 0.001). Both pneumoperitoneum regimes significantly weak-
ened HeLa cell invasion capacity in comparison with those of
controls (p < 0.001 and p < 0.05), whereas HSM profoundly
decreased HeLa cell invasion capacity in comparison with that
of OSM (p < 0.05).
Conclusion: An in vitro model of oxidative stress during CO2-
pneumoperitoneum increased HeLa cancer cell invasion capacity
in comparison with standard CO2-pneumoperitoneum condition
with continuous CO2 insufflation. Oxidative stress followed by
acute hypoxia and reperfusions during deflations can increase
cancer cell attachment and survival capacity, and may trigger
cancer cell invasion and metastasis. These data suggest that a
regime of laparoscopic procedures may affect attachment and
invasion of cancer cells and hence can explain the occurrence
of port-site cancer metastasis.
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Obesity, associated with metabolic syndrome, is considered a
significant risk factor for colorectal cancer (CRC).
Purpose: To compare the levels of metabolic syndrome (MS)
components in persons with CRC and control in the frame of
nested ‘‘case-control” design.
Materials and Methods: The study was carried out on the basis
of a comparison of databases from epidemiological study The
HAPIEE project and CRC register. The patients examined in the
HAPIEE project, who had developed CRC during 10-year follow-
up period according to the register of cancer (n = 92, men-48,
women-44, mean age 60.7 + 6.9 years) were included in analysis.
The control group, matched by sex and age, was also formed from
the HAPIEE database (n = 184, men-96, women-88, mean age
60.7 + 6.8 years). We used MS criteria’s according to NCEP
ATP – III (2001). The data was processed using statistical program
SPSS 13.0.
Results: Body mass index (BMI) and waist circumference (WC)
had no significant differences in the studied groups, the average
BMI value in CRC group was 28.6 + 5.3 kg/m2 vs 28.4 + 5.6 kg/m2
in control (p = 0.70) and WC value in CRC group was
94.1 + 11.7 cm vs 94.1 + 13.6 cm in control (p = 0.90). The percent-
age of patients with abdominal obesity was 41.3% in patients with
CRC vs 42.9% in the control group (p = 0.70).
The average value of total cholesterol was equally high in both
groups (246.8 + 52.5 mg/dL in patients with CRC and 239.8
+ 47.0 mg/dL in the control group), with large individual variation
but no significant difference (p = 0.27). The average level of HDL
cholesterol in CRC group was within normal limits and also did
not differ from control (p = 0.60). The average level of TG in CRC
patients was slightly lower than in the control group:
127.2 + 58.5 mg/dl vs 144.6 + 80.8 mg/dL (p = 0.07). The average
level of glucose did not differ in patients with CRC and in control:
5.9 + 1,2 mmol/l vs 6.1 + 2.1 mmol/L (p = 0.40). In patients with
CRC systolic blood pressure was significantly lower than in con-
trol group: 142.1 + 21.3 mmHg vs 150.4 + 23.7 mmHg (p = 0.005).
The level of diastolic blood pressure was slightly lower than in
the control group compared to CRC (88.9 + 11.2 mmHg
vs91.9 + 13.4 mmHg, p = 0.06). The proportions of patients with
low HDL cholesterol, hypertriglyceridemia and hyperglycemia
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did not differ between the studied groups, but proportion of
hypertension among controls was higher compared to the
patients with CRC (85.3% vs 69.6% p = 0.002).
Conclusions: In studied sample, we did not found the differ-
ences in the values of anthropometric indicators of metabolic
syndrome, cholesterol, HDL cholesterol, triglycerides and glucose
between patients with colorectal cancer and control. Systolic and
diastolic blood pressure as well as hypertension frequency were
significantly lower in CRC group than in the control group. Fur-
ther analysis including stage and localization of CRC is required.
The HAPIEE project is supported by Wellcome Trust
(WT081081AIA).
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The purpose of the study was to access pattern of microRNA
expression in tissue of precancerous lesions and larynx cancer.
A total of 25 people with a diagnosis of dysplasia II–III (n = 10),
control group (dysplasia 0, n = 15) and larynx cancer patients
(n = 46) were examined. Fresh frozen biopsies and adjacent nor-
mal epithelium were used. The diagnosis was verified by histol-
ogy. All qRT-PCR data were analyzed using the Pfaffl analysis.
Multiplex RT-PCR on miRNA templates were performed as
described by Chen et al. (2005). TaqMan miRNA assays (Iyevleva
et al., 2012) were used to quantify expression of mature miRNAs
of interest (miR-18a, -21, -155, -200a, -200c, -205, -221, -494). Data
were analyzed using Welsh t-test with a 5% FDR correction.
According to our results, aberrant expression of some miRNAs
was showed. There was no significant differences in miRNA
expression in a total group (n = 25) although a trend towards over-
expression of oncogenic miRNA-21 and -155 according to severity
of dysplastic changes in a tissue were present. Detailed analysis
showed significant overexpression of that miRNAs as well as
miRNA-200c and -205 in a group of dysplasia II- III against control
group (15 vs 10, p = 0.019, p = 0.045 and p = 0.020, p = 0.038, respec-
tively) but these results did not meet 5% FDR correction.
Data showed overexpression of the same microRNA (-205,
-155, -200 and -21) in larynx cancer patients compared to control
group (46 vs 15, p = 0.0002, p = 0.008, p = 0.009, p = 0.013, respec-
tively). It should be pointed that microRNA pattern both in larynx
cancer and patients with dysplasia II-III was very close showing
similarity of these groups at molecular level. Frequency of cases
with microRNA-205 overexpression was 2.98 times higher in can-
cer patients than in those who had no malignant transformation
(CI 95%, 1.41–16.26, p = 0.007). Data showed that up regulation of
microRNA-205 could be a marker of disease progression
(OR = 4.79). Three other microRNAs did not show any promising
results as biomarkers of cancer progression but data obtained
has interesting fundamental value.
These miRs (-21, -155, -205 and -200c) are known to be regula-
tors of processes that play an emergent role in carcinogenesis and
our results obtained in vivo highlight and expand knowledge
about some aspects of larynx cell transformation. Data suggest
that miRNAs changing its expression according to dysplasia
progress and could be important players in complex process of
carcinogenesis as well as could be potential markers of disease
progression.
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Immunologic microenvironment and some molecular biological
characteristics of breast cancer
I. Novikova, E. Zlatnik, E. Ulyanova, Yu. Shatova. Cancer Research
Institute, Rostov-on-Don, Russian Federation
The purpose of the study was to assess parameters of
local cellular immunity, expression of apoptosis-controlling
proteins and some other receptors in various molecular sub-
types of breast cancer (BC) with different clinical course and
prognosis.
Materials and methods: 100 BC patients aged 30–76 years (59
± 3.4) were recruited. Tissues of tumor and peritumoral area were
homogenized by MediMachine, subset contents of T, B,
NK-lymphocytes were estimated by flow cytometer FACS CantoII.
Percentage of lymphocytes expressing CD3, CD4, CD8, CD19,
CD16/56, were counted from total amount of CD45+ lymphocytes.
Sections of paraffin-embedded blocks were studied by immuno-
histochemical method with polyvalent HRP-DAB detection sys-
tem. Staining was performed using Thermo Scientific
autostainer. Tumor was considered p53-positive when >25% of
tumor cell nuclei were positively stained, and bcl-2-positive when
>25% of cells showed specific cytoplasmic staining. Expression of
E-cadherin was assessed by the number of cells with positive
membrane expression of this marker, taking into account inten-
sity of the reaction. Expression of topoisomerase 2a and androgen
receptors was assessed by the number of tumor cells with
positive nuclear expression of these markers; number of stained
nuclei per 100 nuclei in 3 fields of view was counted.
Results: Some differences characterizing tumor cells of molec-
ular breast cancer subtypes were found. Tumor tissue contained
higher amount of T-lymphocytes than blood (85.9 ± 2.36% vs
60.1 ± 4.5%, P < 0.05) predominantly CD3+CD8+ cells (34.0 ± 1.9%
vs 20.3 ± 5.36%, P < 0.05) but lower percentage of B- and
NK-cells. In tissue of peritumoral area amounts of CD3+ and
CD3+CD8+ cells were also higher, while CD19+ level was lower
than in blood. In the same samples content of CD3+CD4+ was
lower and amount of NK-cells was higher than in tumor tissue.
Triple- negative subtype was characterized by maximal content
of CD3+ lymphocytes (92.2 ± 1.4%), luminal A contained the high-
est amount of CD3+CD16/56+ cells (10.6 ± 1.73%) vs luminal B
(4.34 ± 1.27%) and triple-negative (4.13 ± 1.63%). Her2+ neu BC
demonstrated high amount of NK-cells in peritumoral area but
not in tumor.
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